Sqm and Wesfarmers Announce Final Investment Decision for Mt Holland Lithium Expansion Project
SQM and Wesfarmers said Covalent Lithium has approved a final investment decision to expand the Mt Holland lithium project. The plan adds a new ore sorting facility and second concentrator, targeting output to rise from about 380,000 to 760,000 tonnes per year of 5.5% Li2O spodumene concentrate. SQM’s capex share is estimated at USD 450-500 million, with production starting in 1H 2030.
How this was made
The 30-second read
Why it matters
The expansion adds a second concentrator and a new integrated ore sorting facility, targeting a doubling of nameplate spodumene concentrate production to 760,000 tonnes per year and lower unit operating costs. It also frames optionality to supply downstream processing at Kwinana or sell concentrate.
Market read
Traders can update longer-dated lithium supply and cost expectations based on the disclosed capacity doubling, unit cost reduction claim, and the multi-year capex and ramp schedule.
What to watch
Key sensitivities include permitting/approvals timing, actual realized Li2O grade and recovery, cost inflation on the USD 450-500m SQM capex share, and whether downstream processing demand materializes to justify optionality.
Background
SQM and Wesfarmers operate the Mt Holland lithium project through Covalent Lithium, and the article states a definitive feasibility study has been completed and a final investment decision has been jointly approved.
Ticker impact
SQM and Wesfarmers approved a final investment decision to expand the Mt Holland lithium project via Covalent, doubling spodumene output.
Moderately positive bias, with near-term focus on capex execution and permitting risk rather than immediate earnings.
The article discloses a final investment decision, capacity doubling to 760,000 tpa, and SQM capex share of USD 450-500m, which are concrete drivers for future cash flows. However, it provides no immediate financial guidance or timing beyond construction start in H2 2027 and first volumes in H1 2030.
Market effects
A capacity-doubling project with lower unit costs can influence lithium concentrate supply expectations and cost curves for the spodumene market.
Chile-linked lithium development reinforces South American supply pipeline visibility, though the ramp is multi-year.
Downstream optionality via Kwinana refinery ties concentrate supply to global battery-materials value chain planning.
Counterpoint
Even with a final investment decision, the long timeline to first production (H1 2030) means near-term valuation may hinge more on lithium price assumptions and execution risk than on the headline capacity increase.
Key entities
- companySociedad Química y Minera de Chile S.A. (SQM)
Jointly approved the final investment decision for Mt Holland expansion and is estimated to fund USD 450-500m of the project capex share.
- companyWesfarmers Limited
Joint partner in Covalent Lithium that approved the Mt Holland expansion, including a second concentrator and ore sorting facility.
- joint ventureCovalent Lithium
JV company owned by SQM and Wesfarmers that completed the definitive feasibility study and will execute the expansion.
- assetMt Holland lithium project
Lithium mine and concentrator expansion project, expected to start second concentrator construction in H2 2027 and deliver first concentrate volumes in H1 2030.
- downstream facilityKwinana refinery
Downstream processing site referenced as providing optionality for selling expanded concentrate volumes.
